Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo's Adapalene/BP Gel to Galderma's Epiduo (Adapalene/BP) Gel, and Both Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

NCT03393494 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.

NCT NCT03393494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03393494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo's Adapalene/BP Gel to Galderma's Epiduo (Adapalene/BP) Gel, and Both Treatments to a Vehicle Control in the Treatment of Acne Vulgaris
Lead sponsor
Padagis LLC
Phase
Phase 3
Overall status
Completed
Start date
December 13, 2017
Completion date
January 5, 2019
Enrollment
825 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris